Can Array Technologies (ARRY) Stock Reach $7.50?

Array Technologies, Inc. (ARRY) makes single-axis solar tracking systems used in large utility-scale solar projects, including its DuraTrack, SkyLink and SmarTrack product lines. The stock has fallen sharply through 2026, and the question for investors is whether a beaten-down valuation and a strong order book can power a recovery toward the average analyst price target of roughly $7.50.

Key Takeaways

• The central $7.50 target is the arithmetic mean of roughly two dozen analyst price targets, rounded from about $7.44.
• At a latest verified price near $3.33, reaching $7.50 implies a gain of roughly 125% — a very large move.
• Individual analyst targets span an unusually wide range, from about $4.00 to $13.00, signaling sharp disagreement over the company's outlook.
• The strongest supports are a record order backlog, an expected 2027 recovery, and a recent Mizuho upgrade to Outperform.
• The biggest risks are high leverage, recurring losses, refinancing needs, and tariff and policy uncertainty.

Analyst Price Targets and Consensus View

Array Technologies carries broad but increasingly cautious sell-side coverage. Aggregating current, attributable targets yields a mean near $7.44, which rounds to a central target of $7.50. The full range is unusually wide — roughly $4.00 on the low end to $13.00 on the high end — reflecting genuine disagreement rather than a tidy consensus. The overall rating skews toward Buy, but the distribution has shifted: as of October 2026, hold-equivalent ratings roughly match buy ratings.

The dispersion is telling. More cautious firms have trimmed targets sharply. Barclays cut to $4 from $8, Susquehanna to $4 from $6.75, Piper Sandler to $4 from $5, RBC Capital to $5 from $9, Morgan Stanley to $6 from $8, and JPMorgan to $7 from $8. UBS downgraded the stock to Neutral, cutting its target to $5 from $10, citing the transition of preferred dividends from payment-in-kind to cash, which it argues reduces cash available for deleveraging and growth.

On the other side, Mizuho upgraded ARRY to Outperform with a $5 target, arguing fears of a demand slowdown and cash needs are overdone and expecting a 2027 recovery driven by backlog visibility and operating leverage. Jefferies reinstated coverage with a Buy and a $7 target, while Citi and Goldman Sachs have maintained Buy ratings with targets of $12 and $9, respectively. The gap between a $4 target and a $13 target on the same stock underscores how much hinges on execution and the macro backdrop.

Current Market Position and Path Toward the Target

Array Technologies trades near $3.33, within sight of its 52-week low of about $3.20 and far below its 52-week high of roughly $12.23. A move to the $7.50 central target would require a gain of approximately 125% — by any standard a very large move that would likely require a sustained re-rating, not a single good quarter.

Fundamentally, the company is in transition. Fiscal 2026 guidance calls for revenue of $1.40 billion to $1.50 billion and earnings per share (EPS) of $0.65 to $0.75. The most recent quarter beat expectations, with adjusted EPS of $0.24 versus a $0.12 consensus on revenue of about $342 million. Yet the business remains loss-making on a trailing basis, with negative net income and high leverage, which keeps the forward P/E (price-to-earnings) ratio unusually low but also reflects genuine balance-sheet risk.

What Could Support a Move Toward the Target

Several verified factors could underpin a recovery. The company has pointed to a record backlog and a book-to-bill ratio above one, meaning new orders are outpacing recognized sales and providing revenue visibility into 2027. Product innovation, including the newer DuraTrack D2S tracker and growing software adoption, could strengthen differentiation and share of wallet. The completed acquisition of AWM broadens the platform into complementary balance-of-system products with cross-selling potential into storage and datacenter infrastructure. Analysts such as Mizuho expect above-consensus revenue and margins as the backlog converts and acquisitions contribute operating leverage.

What Could Prevent the Target From Being Reached

The obstacles are equally concrete. Array Technologies carries high debt relative to equity and negative shareholder equity, which limits financial flexibility and raises refinancing sensitivity. The shift of preferred dividends to cash payments reduces free cash flow available for deleveraging, as UBS flagged. Revenue and profitability have been uneven, with recurring losses making the earnings recovery unproven. Policy risk is material: JPMorgan cited potential near-term order slowdowns tied to uncertainty over Section 232 tariffs ahead of an early-December implementation. Competition and project-timing risk in international markets add further execution uncertainty.

Technical Levels and Market Structure

The technical backdrop is weak. The stock sits just above its 52-week low near $3.20, a level that acts as a key support zone; a sustained break below it would open the door to new lows. On the upside, the sharp decline from roughly $12 leaves little in the way of established resistance between current levels and the mid-single digits, but the $4 to $5 zone — where several recent analyst targets cluster — may prove psychologically significant. A durable recovery would first require reclaiming levels well above the current price.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms may differ. The next catalyst is the third-quarter earnings report scheduled for November 5, 2026, where commentary on bookings, delivery timing, refinancing, and tariff exposure will be closely watched. Investors should also track analyst revisions, the early-December Section 232 tariff implementation, and any signs that the backlog is converting into profitable revenue and positive free cash flow.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like Array Technologies, these signals can help traders spot shifting trends, monitor existing positions, and discover opportunities more efficiently than manual scanning. Explore the AI Daily Buy/Sell Signals to see how automated analysis can support your own research process.

Final Assessment

Whether Array Technologies can reach $7.50 depends less on any single catalyst than on whether the company can convert a strong backlog into consistent, profitable revenue while managing an elevated debt load and policy uncertainty. The central target represents a roughly 125% gain from current levels — a very large move that reflects analyst optimism about a 2027 recovery rather than near-term momentum. The unusually wide target range, from about $4 to $13, shows that even the sell-side is sharply divided on the answer. Investors should watch the November earnings report, backlog conversion, tariff developments, and balance-sheet progress before drawing conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations